Abstract
Human umbilical cord blood (CB) represents a unique source of transplantable hematopoietic progenitor cells. Potential advantages of using CB relate to the high number and quality of hematopoietic stem and progenitor cells present in the circulation at birth and to the relative immune immaturity of the newborn immune cells. Discussed in this review are: (a) Quantity and quality of immature hematopoietic stem and progenitor cells from cord blood; (b) Immune cells in cord blood including the number of B- and T-lymphocytes, as well as natural killer cells and characterization of their functional capacities; (c) The need of an international CB transplantation registry and the availability of cord blood banks. Although still in its infancy, human CB progenitor cells hold considerable potential for in vitro expansion and to transplant the adult recipients. In addition, the CB repopulating progenitor cells can serve as targets for gene transfer and long-term treatment of genetic inherited diseases, cancer and some immunodeficiencies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paloczi, K. Immunophenotypic and functional characterization of human umbilical cord blood mononuclear cells. Leukemia 13 (Suppl 1), S87–S89 (1999). https://doi.org/10.1038/sj.leu.2401318
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401318
This article is cited by
-
The effects of platelet-rich plasma derived from human umbilical cord blood on the osteogenic differentiation of human dental stem cells
In Vitro Cellular & Developmental Biology - Animal (2011)